Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma
Authors:
- Lucy KershawLKLucy Kershaw
- Laura ForkerLFLaura Forker
- Darren RobertsDRDarren Roberts
- Benjamin SandersonBSBenjamin Sanderson
- Patrick ShenjerePSPatrick Shenjere
- James WylieJWJames Wylie
- Catherine CoyleCCCatherine Coyle
- Rohit KochharRKRohit Kochhar
- Prakash ManoharanPMPrakash Manoharan
- Ananaya ChoudhuryACAnanaya Choudhury
Open Access
- 1 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 3 (1) , 20200061
Abstract
Objective: Soft tissue sarcoma (STS) is a rare malignancy with a 5 year overall survival rate of 55%. Neoadjuvant radiotherapy is commonly used in preparation for surgery, but methods to assess early response are lacking despite pathological response at surgery being predictive of overall survival, local recurrence and distant metastasis. Multiparametric MR imaging (mpMRI) is used to assess response in a variety of tumours but lacks a robust, standardised method. The overall aim of this study was to develop a feasible imaging protocol to identify imaging biomarkers for further investigation. Methods: 15 patients with biopsy-confirmed STS suitable for pre-operative radiotherapy and radical surgery were imaged throughout treatment. The mpMRI protocol included anatomical, diffusion-weighted and dynamic contrast-enhanced imaging, giving estimates of apparent diffusion coefficient (ADC) and the area under the enhancement curve at 60 s (iAUC60). Histological analysis of resected tumours included detection of CD31, Ki67, hypoxia inducible factor and calculation of a hypoxia score. Results: There was a significant reduction in T1 at visit 2 and in ADC at visit 3. Significant associations were found between hypoxia and pre-treatment iAUC60, pre-treatment ADC and mid-treatment iAUC60. There was also statistically significant association between mid-treatment ADC and Ki67. Conclusion: This work showed that mpMRI throughout treatment is feasible in patients with STS having neoadjuvant radiotherapy. The relationships between imaging parameters, tissue biomarkers and clinical outcomes warrant further investigation. Advances in knowledge: mpMRI-based biomarkers have good correlation with STS tumour biology and are potentially of use for evaluation of radiotherapy response.Keywords
This publication has 34 references indexed in Scilit:
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinomaEuropean Journal of Cancer, 2013
- Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcomaRadiotherapy and Oncology, 2010
- The significance of size change of soft tissue sarcoma during preoperative radiotherapyEuropean Journal of Surgical Oncology, 2010
- Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft-Tissue Sarcomas After Preoperative Concurrent ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Diffusion‐weighted echo‐planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft‐tissue sarcomasJournal of Magnetic Resonance Imaging, 2009
- Radiosensitivity translates into excellent local control in extremity myxoid liposarcomaCancer, 2009
- Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomasJournal of Magnetic Resonance Imaging, 2008
- Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcomaRadiotherapy and Oncology, 2005
- Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heartMagnetic Resonance in Medicine, 2001